NLS Pharmaceutics AG
NASDAQ:NLSP
0.1368 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -4.559 | -7.613 | -7.855 | -8.641 | -7.343 | -4.603 | -1.629 | -1.232 | -2.032 | -3.415 | -0.003 | -0.002 | -1.287 | -1.664 | -1.664 |
| Depreciation & Amortization
| 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 72.188 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0.728 | -0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 1.986 | 0.265 | 0.646 | 0.981 | 2.101 | -5.268 | 1.401 | 0.663 | 1.105 | 3.011 | 0 | -0 | 0.167 | 0.085 | 0.085 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | -0.012 | -0.01 | -0.012 | -0.002 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | -0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 1.521 | 0.74 | -0.149 | 0.785 | 1.21 | -3.479 | 1.25 | 0.247 | 0.655 | 0.723 | 0 | 0.141 | 0.141 | 0.088 | 0.088 |
| Other Working Capital
| 0.466 | -0.474 | 0.795 | 0.196 | 0.903 | -1.779 | 0.163 | 0.418 | 0.449 | 2.288 | 0 | -0 | 0.025 | -0.002 | -0.002 |
| Other Non Cash Items
| -1.33 | -0.683 | 1.149 | -0.785 | -1.154 | 3.632 | -1.207 | -0.208 | -0.632 | 0.394 | 0.002 | 0 | 0.437 | 0.221 | 0.221 |
| Operating Cash Flow
| -2.388 | -7.297 | -6.214 | -7.665 | -5.203 | -9.733 | -0.196 | -0.533 | -0.903 | 0.713 | -0.001 | -0.002 | -0.683 | -1.358 | -1.358 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | -0.007 | -0.033 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | -7.596 | 4.079 | -0.007 | -0.033 | 0.132 | 0.093 | 1.007 | -1.225 | -0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | -0.354 | -0.35 | 0 | -2.105 | -0.648 | -0.542 | -0.155 | -0.513 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 14.163 | 3.938 | 0 | 18.894 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.819 | 0.819 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.002 | 0 | 0.014 | 0.004 | 3.549 | 0.018 | -0.584 | -0.102 | -0.26 | 0.001 | 0.001 | 0 | 0 | -0.819 | -0.819 |
| Financing Cash Flow
| 1.634 | 0 | 13.809 | 3.588 | 3.549 | 16.789 | 0.064 | 0.44 | -0.105 | 0.513 | 0.001 | 0 | 0 | 0.819 | 0.819 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0 | -0 | 0 | 1.654 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -0.754 | -7.297 | 7.594 | -4.077 | -1.661 | 6.998 | -0.052 | -0.075 | 0.219 | 0.001 | -0 | -0.545 | -0.544 | 0.325 | 0.325 |
| Cash At End Of Period
| 0.898 | 1.651 | 8.948 | 1.354 | 5.431 | 7.092 | 0.094 | 0.145 | 0.22 | 1.225 | 0 | 0 | 0.002 | 0.546 | 0.546 |